• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

European Society for Medical Oncology (ESMO) - Articles and news items

cetuximab

Second-line cetuximab active beyond progression in quadruple wild-type patients with mCRC

Industry news / 6 July 2015 / Victoria White

Results from a study on the efficacy of cetuximab plus FOLFOX chemo as second-line treatment for patients with mCRC were presented at the ESMO 2015 congress…

regorafenib

Studies confirm regorafenib benefit in pre-treated metastatic colorectal cancer

Industry news / 3 July 2015 / Victoria White

The Phase IIIb CONSIGN study has confirmed the benefit of regorafenib in patients with previously treated metastatic colorectal cancer (mCRC)…

clinical-trials-regulation

ESMO highlights the opportunities and challenges to come from the EU Clinical Trials Regulation

Industry news / 28 May 2015 / Victoria White

ESMO, in collaboration with EORTC, have expressed their views on the EU Clinical Trials Regulation in an official position paper…

 

Webinar: Different thermal analysis techniques to measure the glass transitionWATCH NOW
+ +